2019
DOI: 10.1038/s41588-019-0528-2
|View full text |Cite
|
Sign up to set email alerts
|

PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
308
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 318 publications
(309 citation statements)
references
References 16 publications
1
308
0
Order By: Relevance
“…To minimize the analytical workload and the risk of incidental findings, only a panel of relevant disease genes is assessed. Obviously, these gene panels need to be constantly updated and various resources for this exist (65).…”
Section: Genetic Testing In Tubulopathiesmentioning
confidence: 99%
“…To minimize the analytical workload and the risk of incidental findings, only a panel of relevant disease genes is assessed. Obviously, these gene panels need to be constantly updated and various resources for this exist (65).…”
Section: Genetic Testing In Tubulopathiesmentioning
confidence: 99%
“…Our work focused on a different group of disorders, IED, and had a number of differences in terms of study design. To reduce the potential impact of misannotation, we focused on (i) genes for which there is broad consensus for their involvement in disease [12] and (ii) variants that are considered to have strong evidence for pathogenicity (those marked as "DM" in HGMD) [13]. We chose to use HGMD (a pay-for-access resource which relies on curation of published literature) over ClinVar (a freely accessible public database which is based on submissions from researchers and clinical diagnostic laboratories) as, at the time of study design, the breadth of coverage of the former appeared to be greater [33].…”
Section: Discussionmentioning
confidence: 99%
“…IED-implicated genes were obtained through PanelApp, a publicly available knowledgebase that combines expert reviews and manual curation to create diagnostic-grade gene lists [12]. We focused on the genes that are included in the different panels within the "ophthalmological disorders" disease category (as of Only genes with a high level of evidence ("green") were retained as our aim was to study variable penetrance in genes robustly associated with disease (rather than to question gene-disease associations).…”
Section: Obtaining Lists Of Genes and Variants Associated With Inherimentioning
confidence: 99%
“…Orphanet (INSERM, 1999;Rath et al, 2012) (a database centred on rare, typically monogenic disease), expertly curated gene panels used for diagnostics from Genomics England PanelApp (Martin et al, 2019) and results from on-going Deciphering Developmental Disorders Study (DECIPHER) -whose aim is to identify de novo micro genomic rearrangements responsible for undiagnosed developmental delay disorders (Firth et al, 2009).…”
Section: Integration Of Mendelvar Data Sourcesmentioning
confidence: 99%